About 118,000 results
Open links in new tab
  1. EMPAVELI, a complement inhibitor, increases the risk of serious infections, especially those caused by encapsulated bacteria, such as Streptococcus pneumoniae, Neisseria meningitidis, and...

  2. EMPAVELI is available only through a restricted program under a REMS called EMPAVELI REMS, because of the risk of serious infections caused by encapsulated bacteria [see Warnings and …

  3. Empaveli: Package Insert / Prescribing Information / MOA

    Aug 6, 2025 · Complete or update vaccination for encapsulated bacteria at least 2 weeks prior to the first dose of EMPAVELI, unless the risks of delaying EMPAVELI outweigh the risks of developing a …

  4. EMPAVELI (pegcetacoplan) | Patient Informational Website

    If you have PNH and you stop taking EMPAVELI, your healthcare provider will need to monitor you closely for at least 8 weeks after stopping EMPAVELI. Stopping treatment with EMPAVELI may …

  5. Empaveli (Apellis Pharmaceuticals, Inc.): FDA Package Insert

    Jul 30, 2025 · EMPAVELI, a complement inhibitor, increases the risk of serious infections, especially those caused by encapsulated bacteria, such as Streptococcus pneumoniae , Neisseria meningitidis …

  6. These highlights do not include all the information needed to use ...

    Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. EMPAVELI is a clear, colorless to slightly …

  7. Use of Empaveli may predispose individuals to serious infections, especially those caused by encapsulated bacteria, such as S. pneumoniae, N. meningitidis types A, C, W, Y and B, and H. …

  8. Empaveli: Uses, Dosage, Side Effects, Warnings - Drugs.com

    Dec 24, 2025 · How long does the Empaveli injector take to deliver the dose? The infusion time with the Empaveli injector varies but is designed to deliver the full dose while allowing you to move around …

  9. If you are changing treatment from ravulizumab to EMPAVELI, you should take your starting dose of EMPAVELI no more than 4 weeks after your last dose of ravulizumab.

  10. • If you are changing treatment from ravulizumab to EMPAVELI, you should take your starting dose of EMPAVELI no more than 4 weeks after your last dose of ravulizumab.